Search Results - Charles Link

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Embryonic Stem Cells As an Alternate Marrow Donor Source

    Embryonic Stem Cells As an Alternate Marrow Donor Source by Richard K. Burt, Larissa Verda, Duck-An Kim, Yu Oyama, Kehuan Luo, Charles Link

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors

    A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors by Hatem Soliman, Erica L. Jackson, Tony Neuger, Elizabeth Claire Dees, R. Donald Harvey, Hyo S. Han, Roohi Ismail‐Khan, Susan Minton, Nicholas N. Vahanian, Charles Link, Daniel M. Sullivan, Scott Antonia

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    A phase I study of indoximod in patients with advanced malignancies

    A phase I study of indoximod in patients with advanced malignancies by Hatem Soliman, Susan Minton, Hyo S. Han, Roohi Ismail‐Khan, Anthony Neuger, Fatema Khambati, David Noyes, Richard M. Lush, Alberto Chiappori, John D. Roberts, Charles Link, Nicholas N. Vahanian, Mario R. Mautino, Howard Streicher, Daniel M. Sullivan, Scott Antonia

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer

    Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer by Veronica Mariotti, Hyo S. Han, Roohi Ismail‐Khan, Shou‐Ching Tang, Patrick M. Dillon, Alberto J. Montero, Andrew Poklepovic, Susan A. Melin, Nuhad K. Ibrahim, Eugene P. Kennedy, Nicholas N. Vahanian, Charles Link, Lucy Tennant, Shelly Schuster, Christopher R. Smith, Oana Danciu, Paul Gilman, Hatem Soliman

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

    Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-respons... by D. Gray Heppner, Tracy Kemp, Brian K. Martin, W. Jay Ramsey, Richard Nichols, Emily J. Dasen, Charles J. Link, Rituparna Das, Zhi Jin Xu, Eric Sheldon, Teresa Nowak, Thomas P. Monath, DG Heppner, TL Kemp, B R Martin, WJ Ramsey, Richard Nichols, EJ Dasen, Joan Fusco, Joseph Crowell, Charles Link, J Creager, TP Monath, Rituparna Das, ZJ Xu, Ronald Klein, Tristan Nowak, Eric Gerstenberger, Robin Bliss, EA Sheldon, Ricardo A. Feldman, Brandon Essink, W. Bradford Smith, Laurence Chu, WM Seger, Jamshid Saleh, JL Borders, Malcolm Adams

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: